Abstract
Ganoderma lucidum is known to exert many health benefits including effects to improve oxygen utilization. Therefore, this study was designed to evaluate the role of a hydroalcoholic G. lucidum extract in providing tolerance to HT22 cells grown under hypoxic conditions. HT22 cells were exposed to 0.5% O2 in the presence or absence of the extract for 24 hours. At the end of the exposure period, we performed cell viability assays, cell cycle analysis, and biochemical and protein expression studies. The extract-treated cells revealed less cell death, minimized caspase 3 and reactive oxygen species levels, and relieved G0/G1 cell cycle arrest compared with hypoxic cells cultured without the extract. Further, extract-treated cells showed improved expression of Nrf2, heme oxygenase 1, and metallothionein and stabilized levels of hypoxia-inducible factor 1α. Moreover, lower levels of nuclear factor-κB and tumor necrosis factor α were evident in extract-treated cells. Overall, the G. lucidum extract reduced hypoxia-induced cell death and augmented transcription factors (HIF-1α and Nrf2), conferring tolerance to hypoxia.
Original language | English |
---|---|
Pages (from-to) | 431-444 |
Number of pages | 14 |
Journal | International Journal of Medicinal Mushrooms |
Volume | 20 |
Issue number | 5 |
DOIs | |
State | Published - 2018 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2018 Begell House, Inc.
Funding
The authors thank the Director of Defence Institute of Physiology and Allied Sciences, Delhi, India, for constructive suggestions and the Director of Defence Institute of Bio-Energy Research, Pithoragarh, India, for providing study material. The study was funded by the Defence Research and Development Organisation, Ministry of Defence, India.
Funders | Funder number |
---|---|
Defence Research and Development Organisation | |
Ministry of Defence |
Keywords
- Chinese medicine
- Ganoderma lucidum
- Hypoxia
- Hypoxia-inducible factor
- Medicinal mushrooms